A successful pregnancy with a normal baby in a woman with acute promyelocytic leukemia treated with daunorubicin from the ninth week of gestation is reported. Daunorubicin is an effective agent against this leukemia during pregnancy. That daunorubicin may be safely used, when required during the early gestation, is suggested.
No takes yet. Share an insight, caveat, or question.
Alegre et al. (1982) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: